DE602005013385D1 - Verwendung von Kollagen in Kombination mit Sauerstoff- und Ozon-freisetzenden Perfluorkohlenwasserstoffen zur Herstellung eines Medikaments zur Behandlung von Hautverletzungen - Google Patents

Verwendung von Kollagen in Kombination mit Sauerstoff- und Ozon-freisetzenden Perfluorkohlenwasserstoffen zur Herstellung eines Medikaments zur Behandlung von Hautverletzungen

Info

Publication number
DE602005013385D1
DE602005013385D1 DE602005013385T DE602005013385T DE602005013385D1 DE 602005013385 D1 DE602005013385 D1 DE 602005013385D1 DE 602005013385 T DE602005013385 T DE 602005013385T DE 602005013385 T DE602005013385 T DE 602005013385T DE 602005013385 D1 DE602005013385 D1 DE 602005013385D1
Authority
DE
Germany
Prior art keywords
medicament
ozone
oxygen
treatment
releasing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005013385T
Other languages
English (en)
Inventor
Filippo Ernestino Parodi
Franco Papa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE602005013385D1 publication Critical patent/DE602005013385D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
DE602005013385T 2005-10-20 2005-10-20 Verwendung von Kollagen in Kombination mit Sauerstoff- und Ozon-freisetzenden Perfluorkohlenwasserstoffen zur Herstellung eines Medikaments zur Behandlung von Hautverletzungen Active DE602005013385D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05425735A EP1776960B1 (de) 2005-10-20 2005-10-20 Verwendung von Kollagen in Kombination mit Sauerstoff- und Ozon-freisetzenden Perfluorkohlenwasserstoffen zur Herstellung eines Medikaments zur Behandlung von Hautverletzungen

Publications (1)

Publication Number Publication Date
DE602005013385D1 true DE602005013385D1 (de) 2009-04-30

Family

ID=36570425

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005013385T Active DE602005013385D1 (de) 2005-10-20 2005-10-20 Verwendung von Kollagen in Kombination mit Sauerstoff- und Ozon-freisetzenden Perfluorkohlenwasserstoffen zur Herstellung eines Medikaments zur Behandlung von Hautverletzungen

Country Status (6)

Country Link
US (1) US20080260787A1 (de)
EP (1) EP1776960B1 (de)
AT (1) ATE425765T1 (de)
DE (1) DE602005013385D1 (de)
ES (1) ES2325274T3 (de)
WO (1) WO2007045982A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2651039C1 (ru) * 2017-04-17 2018-04-18 Федеральное Государственное Бюджетное Образовательное Учреждение Высшего Образования "Красноярский Государственный Медицинский Университет Имени Профессора В.Ф. Войно-Ясенецкого Министерства Здравоохранения Российской Федерации" Способ местного лечения гнойных ран локальным потоком озоно-кислородной газовой смеси при сахарном диабете ii типа

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789663A (en) * 1984-07-06 1988-12-06 Collagen Corporation Methods of bone repair using collagen
US4760131A (en) * 1986-04-23 1988-07-26 Collagen Corporation Wound-healing composition
IL84911A (en) 1987-12-22 1993-04-04 Yissum Res Dev Co Processes for the preparation of collagen products, and pharmaceutical compositions containing the same
CA2071137A1 (en) * 1991-07-10 1993-01-11 Clarence C. Lee Composition and method for revitalizing scar tissue
US5344393A (en) * 1992-02-28 1994-09-06 Alliance Pharmaceutical Corp. Use of synthetic oxygen carriers to facilitate oxygen delivery
US5660857A (en) * 1993-03-22 1997-08-26 Johnson & Johnson Medical Inc. Biopolymer composites
FR2710840B1 (fr) * 1993-10-04 1995-12-01 Applic Transferts Technolo Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
CA2480141A1 (en) 2002-03-28 2003-10-09 Exponential Biotherapies, Inc. Oxygenating agents for enhancing host responses to microbial infections
WO2006084353A1 (en) * 2005-02-14 2006-08-17 Dpm Therapeutics Corp. Stabilized compositions for topical administration and methods of making same

Also Published As

Publication number Publication date
EP1776960A1 (de) 2007-04-25
ATE425765T1 (de) 2009-04-15
US20080260787A1 (en) 2008-10-23
EP1776960B1 (de) 2009-03-18
WO2007045982A3 (en) 2007-10-04
ES2325274T3 (es) 2009-08-31
WO2007045982A2 (en) 2007-04-26

Similar Documents

Publication Publication Date Title
MX2010004074A (es) Combinacion 059.
EA200801717A1 (ru) Композиция местного применения по уходу за кожей, продукт на ее основе и способ лечения
DE602006007093D1 (de) Kombinationstherapie zur Behandlung von Diabetes und dadurch bedingten Leiden sowie zur Behandlung von mittels Erhöhung des GLP-1-Spiegels im Blut verbesserten Leiden
GB2441939A (en) Surgical membrane
WO2008103993A3 (en) Compositions and methods for treating glycogen storage diseases
CY1117603T1 (el) Η λιξισενατιδη ως προσθετο στη μετφορμινη στην θεραπευτικη αγωγη του διαβητη τυπου 2
ATE502633T1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
ATE489957T1 (de) Mittel zur behandlung von entzündlichen erkrankungen
WO2006035237A3 (en) Methods and compositions relating to alzheimer's disease
HUP0301749A2 (hu) Acilfenil-karbamid-származékok, eljárás az elżállításukra és gyógyszerkénti alkalmazásuk
DE602004031134D1 (de) Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa
ECSP066770A (es) Nuevos ésteres de quinuclidina cuaternizados
ATE373474T1 (de) Substituierte 2-aminotetraline zur behandlung von depressionen
ATE367167T1 (de) Aufbereitung von aldesleukin zur pharmazeutischen verwendung
CY1111353T1 (el) Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης
ATE443722T1 (de) Peptide und peptidderivate, ihre herstellung sowie ihre verwendung zur herstellung einer therapeutisch und/oder prophylaktisch wirksamen pharmazeutischen zusammensetzung
ATE531703T1 (de) Benzochromenderivate
NO20076405L (no) Anvendelse av 24-nor-UDCA
DE602005013385D1 (de) Verwendung von Kollagen in Kombination mit Sauerstoff- und Ozon-freisetzenden Perfluorkohlenwasserstoffen zur Herstellung eines Medikaments zur Behandlung von Hautverletzungen
DE602005013542D1 (de) Behandlung der oralen und darm mukositis durch verabreichung von menschlichem il-18
ATE527997T1 (de) Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien
ATE491443T1 (de) Verwendung des agomelatins zur herstellung eines medikamentes zur behandlung der bipolaren erkrankungen
WO2012075244A3 (en) Use of hemoglobin effectors to increase the bioavailability of therapeutic gases
GEP20125638B (en) Use of s-adenosylmethionine (sam) and superoxide dismutase (sod) for the preparation of medicaments for the treatment of alzheimer's disease
DE602004007304D1 (de) Verwendung von N2O zur Behandlung von postischemischen cerebralen zellulären Beschädigungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KUDLEK & GRUNERT PATENTANWAELTE PARTNERSCHAFT, 803